Skip to main content
Andor Glaudemans
prof. dr.

I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.

Use of [11C]choline PET/CT for visualization of four hyperactive parathyroid glands in a patient with renal hyperparathyroidism
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document 10.1007/s00259-022-05885-8 document
Matti Raitza, Aziz A N Alshalali, Andor W J M Glaudemans, Rijk O B Gans, Riemer H J A Slart
EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document 10.1007/s00259-022-05919-1 document
PURPOSE: Current European Association of Nuclear Medicine (EANM) Research Ltd. (EARL) guidelines for the standardisation of PET imaging developed for conventional systems have not yet been adjusted for long axial field-of-view (LAFOV) systems. In order to use the LAFOV Siemens Biograph Vision Quadra PET/CT (Siemens Healthineers, Knoxville, TN, USA) in multicentre research and harmonised clinical use, compliance to EARL specifications for 18F-FDG tumour imaging was explored in the current study. Additional tests at various locations throughout the LAFOV and the use of shorter scan durations were included. Furthermore,...
Joyce van Sluis, Johannes H van Snick, Adrienne H Brouwers, Walter Noordzij, Rudi A J O Dierckx, Ronald J H Borra, Riemer H J A Slart, Adriaan A Lammertsma, Andor W J M Glaudemans, Ronald Boellaard, Charalampos Tsoumpas
Teaching cases in nuclear oncology: Breast cancer
Published in: Nuclear Oncology
Access to document 10.1007/978-3-031-05494-5_62 document
A 76-year-old woman with a recent diagnosis of invasive ductal carcinoma of the left breast (6 cm in size) and suspected left axillary lymph node involvement was referred for [18F]FDG PET/CT for staging.
Alice Lorenzoni, Alessandra Alessi, Flavio Crippa, S. Shammari, F. Fraioli, E. D. Telenga, R. H.J.A. Slart, A. W.J.M. Glaudemans
2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document 10.1007/s00259-022-05881-y document
Richard Graham, Ana P Moreira, Andor W J M Glaudemans, Lars Thorbjørn Jensen, Jasna Mihaïlovic, Sergei Nazarenko, Zehra Ozcan, Doina Piciu, Wolfgang Wadsak, Jolanta Kunikowska, François Jamar
First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document 10.1007/s00259-022-05777-x document
Adrienne H Brouwers, Joyce van Sluis, Johannes H van Snick, Carolina P Schröder, Inge O Baas, Ronald Boellaard, Andor W J M Glaudemans, Ronald J H Borra, Adriaan A Lammertsma, Rudi A J O Dierckx, Charalampos Tsoumpas